LAU-7b featured in The Pharmaceutical Journal among next-generation antivirals targeting COVID-19
LAU-7b featured in The Pharmaceutical Journal (The Royal Pharmaceutical Society) among next-generation antivirals targeting COVID-19
Laurent Pharma to participate to Biotech Showcase Conference
Laurent Pharma to participate to Biotech Showcase Conference, January 9-11, 2023 – San Francisco, CA, USA
Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b in Cystic Fibrosis at the NACFC 2022
LAU-7b first inflammation-controlling drug to demonstrate clinical benefit in adults with CF, complementary to administration of CFTR modulators.Study achieves clinically meaningful reduction in lung function loss at 6 months, measured…